This year marks the launch of TKI-LSH’s innovative PPP subsidy scheme, a consortium-based initiative allowing funded Programs to develop partnerships with industry, by issuing Calls for projects, allocate resources, and oversee their implementation. With a total of 15 programs awarded in 2025, this approach is set to tackle prominent matters of healthcare and aim to provide substantial and tangible advancements within the Life Sciences & Health sector, by working closely with companies and third parties in the respective field.
Four program applications having UMCG as partner have been positively assessed in this funding round. UMCG and its Program partners are proud to collaborate in impactful and innovative initiatives in Life Sciences & Health, within the fields of organ transplantation, drug development and imaging, dementia care, and oral health.
A total amount of 7,450,000 EUR PPP subsidy has been allocated to the Programs for the year 2025; the UMCG will act as the main Coordinator in three of these awarded Programs. Notably each program has its own organization and will structure open calls for PPP projects in the respective fields in the coming months.
The awarded programs are:
IMPACT - Innovative Machine Perfusion for Advancing Clinical Transplantation
The IMPACT program focuses on advancing machine perfusion technologies to improve organ preservation, assessment, and repair. By leveraging cutting-edge research and collaborations with top institutions and private sector partners, this initiative among the Transplantation Centers of the UMCG, as main coordinator, and program partner ErasmusMC aims to enhance organ viability, promote regeneration, and reduce immunogenicity. Through these innovations, the Netherlands will further strengthen its position as a global leader in organ transplantation.
FORESIGHT - Improving drug development and choices with molecular imaging
FORESIGHT is transforming drug development by using advanced molecular imaging to track medicines in the body and identify the best treatment for each patient. This innovative approach makes drug development faster, more effective, and more personalized, helping to bring better treatments to those who need them most.
The FORESIGHT program is a joint effort between the main coordinator UMCG, and its partner from Amsterdam UMC, NKI/AVL, and TU Eindhoven, in which multidisciplinary teams with expertise in tracer development, bioengineering, imaging, and AI-driven data analysis collaborate. FORESIGHT supports medical teams conducting (pre)clinical molecular imaging studies in the fields of oncology, autoimmune diseases, cardiovascular conditions, and neurodegenerative disorders.
DEMTECH Program - Innovative Technologies for People with Dementia: Supporting Changing Care Needs and Improving Quality of Life
The DEMTECH program aims to develop user-friendly technologies, to support both the physical and emotional needs of individuals with dementia. By addressing key challenges such as usability, interoperability, and scalability, DEMTECH seeks to make meaningful advancements in dementia care while also alleviating the workload of healthcare professionals.
The DEMTECH program is a joint initiative between the UMCG as main coordinator and its partners Alzheimer Nederland, Vilans, Hanzehogeschool Groningen, Eindhoven University of Technology and Sara B.V.
ORANGEHealth: shape the future of oral and general health
ORANGEHealth (ORal AND GEneral Health) is an initiative dedicated to driving innovation and collaboration within the oral healthcare sector. Since 2020, seven Dutch universities and applied sciences institutions have worked alongside private sector partners to enhance oral health through the strategic public-private partnership ORANGEHealth.
The program aims to integrate oral healthcare more effectively with general healthcare by focusing on three key pillars: Research & Development, Data Infrastructure & Monitoring, and Field Labs & Implementation. Through these efforts, ORANGEHealth seeks to tackle critical challenges such as treatment variation and rising healthcare costs.
The initiative is led by Radboudumc as main coordinator together with the program partners Hogeschool Utrecht, Academisch Centrum Tandheelkunde Amsterdam, Hogeschool van Arnhem en Nijmegen, Hanzehogeschool Groningen.
More information about the respective Program details will follow in the coming months.
Health Holland has awarded a total of 15 programs for a total of 40.000.000 EUR PPP 2025 subsidy. Every program will organize funding Calls in the coming months.
To all UMCG researchers that have potential PPP projects in development , we recommend to keep an eye of the program developments. The overview of topics and managing partners is available at Programs | Health~Holland. If you require additional information on the Programs, please contact the UMCG Innovation Center.
The Health Holland PPP Program Call will be launched on yearly basis. The new round is expected to be announced in the coming months.
The UMCG and the Innovation Center are proud to contribute to these initiatives, which will significantly impact patient care, research, and technological development within the healthcare sector. These Programs highlight our dedication to supporting innovation through collaboration, ensuring that healthcare remains accessible, affordable, and of the highest quality.
We look forward to the progress these Programs will bring and will continue to provide updates on our contributions to these advancements in medical science and healthcare solutions.
Any question? For general information, please contact [email protected]
